S. Akimoto

发表

Androgen receptor content of prostate carcinoma cells estimated by immunohistochemistry is related to prognosis of patients with stage D2 prostate carcinoma

K. Akakura, H. Takeda, M. Masai, 1996, Cancer.

DISEASE PROGRESSION IN STAGE A PROSTATE CANCER

K. Akakura, M. Masai, S. Akimoto, 1995, International journal of urology : official journal of the Japanese Urological Association.

Codon 877 Mutation in the Androgen Receptor Gene in Advanced Prostate Cancer: Relation to Antiandrogen Withdrawal Syndrome

K. Akakura, Hiroyoshi Suzuki, S. Akimoto, 1996, The Prostate.

Short Communication Expression of the KAl1 Protein in Benign Prostatic Hyperplasia and Prostate Cancer

Imai, K. Akakura, H. Ito, 2007 .

[Relationship between extent of bone metastases and effect of endocrine therapy evaluated with bone scintigraphy in stage D2 prostatic cancer].

M. Masai, S. Akimoto, J. Shimazaki, 1992, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Long-term results of a randomized trial for the treatment of Stages B2 and C prostate cancer: radical prostatectomy versus external beam radiation therapy with a common endocrine therapy in both modalities.

Y. Ohashi, K. Akakura, O. Yoshida, 1999, Urology.

Incidence and Characteristics of Antiandrogen Withdrawal Syndrome in Prostate Cancer after Treatment with Chlormadinone Acetate

Y. Furuya, K. Akakura, S. Akimoto, 1998, European Urology.

Relationship of Prostate-Specific Antigen Levels to Prostate Volume and Age in Mass Screening Subjects

T. Ichikawa, S. Akimoto, Haruo Ito, 1998, Urologia Internationalis.

Relationship between diurnal rhythm of serum testosterone and two prostatic markers (PSA and PAP) in untreated prostate cancer.

M. Masai, S. Akimoto, J. Shimazaki, 1994, Urology.

The natural history of benign prostatic hyperplasia.

S. Akimoto, J. Shimazaki, 1997, Harvard men's health watch.

Natural course of human benign prostatic hyperplasia with relation to urinary disturbance

T. Ichikawa, S. Akimoto, J. Shimazaki, 1994, The Prostate.

A prospective randomized trial for treating stages B2 and C prostate cancer: radical surgery or irradiation with neoadjuvant endocrine therapy.

O. Yoshida, T. Kakizoe, S. Akimoto, 1994, Japanese journal of clinical oncology.

Argyrophilic nucleolar organizer regions in benign hyperplastic and cancerous human prostates

M. Masai, S. Akimoto, R. Yatani, 1992, The Prostate.

Antiandrogen withdrawal syndrome in prostate cancer after treatment with steroidal antiandrogen chlormadinone acetate.

K. Akakura, S. Akimoto, J. Shimazaki, 1995, Urology.

Immunohistochemical study of androgen receptor in benign hyperplastic and cancerous human prostates

Chawnshang Chang, M. Masai, S. Akimoto, 1990, The Prostate.

Sex steroid-binding protein in a subline of Dunning R 3327 prostatic adenocarcinoma of the rat.

H. Fuse, S. Akimoto, J. Shimazaki, 1984, Endocrinologia japonica.

Effect of leuprolide on growth of rat prostatic tumor (R 3327) and weight of male accessory sex organs.

T. Ichikawa, S. Akimoto, J. Shimazaki, 1988, Endocrinologia japonica.

Prognostic Value of the Serum Levels of Bone Formation and Bone Resorption Markers in Prostate Cancer Patients with Bone Metastasis

Y. Furuya, K. Akakura, S. Akimoto, 1998, European Urology.

Influence of Osteoarthritis on Serum Marker Levels of Bone Formation and Resorption in Patients with Benign Prostatic Hypertrophy

Y. Furuya, K. Akakura, H. Ito, 1997, International journal of urology : official journal of the Japanese Urological Association.

Changes in histologic grade and argyrophilic nucleolar organizer regions during progression of prostate cancer.

K. Akakura, S. Akimoto, R. Yatani, 1996, Japanese journal of clinical oncology.

Progression and selection in heterogeneous tumor composed of androgen-responsive Shionogi carcinoma 115 and its autonomous subline (Chiba subline 2).

T. Ichikawa, S. Akimoto, J. Shimazaki, 1989, Cancer research.

Relationship Between Serum Tumor Necrosis Factor-a and in Prostate Cancer Patients levels of lnterleukin-6 , Bone Turnover Markers

S. Akimoto, Okumura, AKIou, 2006 .

Relationship between serum levels of interleukin-6, tumor necrosis factor-alpha and bone turnover markers in prostate cancer patients.

S. Akimoto, A. Okumura, H. Fuse, 1998, Endocrine journal.

Androgen receptor, testosterone uptake and karyotype in androgen-dependent mouse tumor (SC 115) and its androgen-independent subline (CS 2).

T. Ichikawa, S. Akimoto, J. Shimazaki, 1987, Endocrinologia japonica.

Modalities of chemotherapy and endocrine therapy for growth inhibition of androgen‐stimulated mouse carcinoma (shionogi carcinoma 115)

T. Ichikawa, S. Akimoto, J. Shimazaki, 1987, The Prostate.

Properties of progestin-binding protein in benign hypertrophic human prostate.

H. Fuse, S. Akimoto, J. Shimazaki, 1986, Endocrinologia japonica.

Binding of mibolerone to androgen receptor of benign hypertrophic human prostate. Comparison with R1881.

H. Fuse, S. Akimoto, J. Shimazaki, 1985, Endocrinologia japonica.

Changes in cytosolic androgen receptor after administration of testosterone of androgen-dependent mouse mammary tumor (Shionogi carcinoma) and its sublines of altered androgen dependency.

H. Fuse, S. Akimoto, J. Shimazaki, 1983, Endocrinologia japonica.

Comparison of various assay systems for prostate-specific antigen standardization.

H. Akaza, Y. Kawada, S. Akimoto, 1992, Japanese journal of clinical oncology.

[Clinical course of bone metastases by prostatic cancer studies with conventional X-ray].

S. Akimoto, J. Shimazaki, S. Goto, 1991, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

[Endocrine therapy of stage D2 prostatic carcinoma].

H. Fuse, K. Akakura, S. Akimoto, 1988, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Comparison of Markers of in Prostate Cancer Patients Bone Formation and Resorp to Predict Bone Metastasis tion

S. Akimoto, Akakura, Koichiro, 2006 .

Characteristics of progestin binder in hypertrophic human prostate.

K. Akakura, S. Akimoto, J. Shimazaki, 1988, Endocrinologia japonica.

Mesenteric Castleman tumor.

K. Hamano, S. Akimoto, T. Mikami, 1983, Journal of computer assisted tomography.

[Usefulness of hyper sensitive PSA assay kits for determination on low range of prostate specific antigen in prostate cancer].

K. Akakura, Y. Kawada, S. Akimoto, 1995, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Prognosis of Patients with Prostate Carcinoma Presenting as Nonregional Lymph Node Metastases

Y. Furuya, K. Akakura, S. Akimoto, 1998, Urologia Internationalis.

Chemotherapy for endocrine-therapy-refractory prostate cancer

K. Akakura, M. Masai, S. Akimoto, 2004, Cancer Chemotherapy and Pharmacology.

Pain caused by bone metastasis in endocrine-therapy-refractory prostate cancer

K. Akakura, S. Akimoto, J. Shimazaki, 2005, Journal of Cancer Research and Clinical Oncology.

[Determination of tumor marker doubling time in the patients with prostate cancer relapsed from endocrine therapy].

M. Masai, S. Akimoto, J. Shimazaki, 1993, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

[Response to chemotherapy in endocrine therapy-relapsed and -resistant prostate cancer].

K. Akakura, M. Masai, S. Akimoto, 1991, Hinyokika kiyo. Acta urologica Japonica.

State of Adenomatous Polyposis Coli Gene and ras Oncogenes in Japanese Prostate Cancer

T. Igarashi, Hiroyoshi Suzuki, S. Akimoto, 1994, Japanese journal of cancer research : Gann.

Expression of the KAI1 protein in benign prostatic hyperplasia and prostate cancer.

K. Akakura, H. Ito, A. Mikata, 1996, The American journal of pathology.

Apoptosis of androgen-independent prostate cell line induced by inhibition of fatty acid synthesis.

Y. Furuya, H. Ito, S. Akimoto, 1997, Anticancer research.

Prognostic factors in patients with prostate cancer refractory to endocrine therapy: univariate and multivariate analyses including doubling times of prostate-specific antigen and prostatic acid phosphatase.

K. Akakura, H. Ito, S. Akimoto, 1997, Japanese journal of clinical oncology.

[Measurement of serum PA values by a newly developed enzyme immunoassay].

T. Deguchi, Y. Kawada, S. Akimoto, 1993, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Clinical Evaluation of Serum Prostate‐Specific Antigen‐Alpha1 ‐ Antichymotrypsin Complex Values in Diagnosis of Prostate Cancer: A Cooperative Study

H. Uno, Y. Nasu, Y. Arai, 1998, International journal of urology : official journal of the Japanese Urological Association.

Determination of serum prostate-specific antigen-alpha1-antichymotrypsin complex for diagnosis of prostate cancer in Japanese cases.

T. Niwa, P. Abrahamsson, S. Akimoto, 2001, Scandinavian journal of urology and nephrology.

Effect of naftopidil on urethral obstruction in benign prostatic hyperplasia: Assessment by urodynamic studies

T. Yamanishi, S. Akimoto, J. Shimazaki, 1994, The Prostate.

Relationship between Prostate‐Specific Antigen, Clinical Stage, and Degree of Bone Metastasis in Patients with Prostate Cancer: Comparison with Prostatic Acid Phosphatase and Alkaline Phosphatase

Y. Furuya, K. Akakura, H. Ito, 1997, International journal of urology : official journal of the Japanese Urological Association.

Inability of bone turnover marker as a strong prognostic indicator in prostate cancer patients with bone metastasis: Comparison with the extent of disease (EOD) grade

Y. Furuya, K. Akakura, H. Ito, 1999, The Prostate.

Smoking and Obesity in Relation to the Etiology and Disease Progression of Prostate Cancer in Japan

Y. Furuya, K. Akakura, H. Ito, 1998, International journal of urology : official journal of the Japanese Urological Association.

Comparison of markers of bone formation and resorption in prostate cancer patients to predict bone metastasis.

Y. Furuya, K. Akakura, H. Ito, 1998, Endocrine journal.

Histochemical examination of expression of ras p21 protein and R 1881-binding protein in human prostatic cancers.

M. Masai, S. Akimoto, R. Yatani, 1990, European journal of cancer.

[Clinical evaluation of TANDEM PSA in Japanese cases and comparison with other methods].

Y. Kawada, S. Akimoto, J. Shimazaki, 1995, Hinyokika kiyo. Acta urologica Japonica.

Title Inverted papilloma of the renal pelvis associated with renal cell carcinoma: a case report

S. Akimoto, K. Nagao, J. Matsuzaki, 2016 .

Inverted papilloma of the renal pelvis associated with renal cell carcinoma: a case report.

K. Nagao, S. Akimoto, J. Shimazaki, 1992, Hinyokika kiyo. Acta urologica Japonica.

DIURNAL RHYTHM OF SERUM gM‐SEMINOPROTEIN IN PATIENTS WITH UNTREATED PROSTATE CANCER: COMPARISON OF THE ORIGINAL AND REVISED ASSAY KITS

K. Akakura, S. Akimoto, J. Shimazaki, 1994, International journal of urology : official journal of the Japanese Urological Association.

[Usefulness of fine needle aspiration cytology in the diagnosis of prostate cancer].

S. Akimoto, J. Shimazaki, T. Nakamura, 1995, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

[Clinical study of RU 23908 (nilutamide) in prostatic cancer].

H. Fuse, H. Akaza, H. Yamanaka, 1991, Hinyokika kiyo. Acta urologica Japonica.

Microsatellite Instability and Other Molecular Abnormalities in Human Prostate Cancer

T. Igarashi, T. Shiraishi, Hiroyoshi Suzuki, 1995, Japanese journal of cancer research : Gann.

ON CUSHING ' S SYNDROME

H. Fuse, S. Akimoto, J. Shimazaki, 2010 .

Prostate‐Specific Antigen Levels from a Mass Screening Program Using Highly Sensitive RIA Kits

K. Akakura, T. Ichikawa, S. Akimoto, 1997, International journal of urology : official journal of the Japanese Urological Association.

Clinical course of bone metastasis from prostatic cancer following endocrine therapy: examination with bone x-ray.

M. Masai, S. Akimoto, J. Shimazaki, 1992, Advances in experimental medicine and biology.

Clinical usefulness of serum carboxyterminal propeptide of type I procollagen and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen in patients with prostate cancer.

K. Akakura, S. Akimoto, J. Shimazaki, 1996, Japanese journal of clinical oncology.

Serum gamma-seminoprotein determination in prostatic cancer.

K. Akakura, O. Yoshida, K. Okada, 1991, Hinyokika kiyo. Acta urologica Japonica.

SERUM r-SEMINOPROTEIN DETERMINATION IN PROST A TIC CANCER

K. Akakura, O. Yoshida, K. Okada, 1991 .

[Clinical evaluation of a new kit (IMX PA Dainapack) for detection of serum prostate specific antigen].

T. Wada, Y. Ohishi, M. Yokoyama, 1993, Hinyokika kiyo. Acta urologica Japonica.

Association between clinical stage of prostate cancer and pathological findings of random systematic transperineal core biopsy under transrectal ultrasonography

Y. Furuya, K. Akakura, H. Ito, 1999, International Journal of Clinical Oncology.

Pattern of progression and survival in hormonally treated metastatic prostate cancer

Y. Furuya, K. Akakura, H. Ito, 1999, International journal of urology : official journal of the Japanese Urological Association.

Radiotherapy for local progression in patients with hormone‐refractory prostate cancer

Y. Furuya, K. Akakura, H. Ito, 1999, International journal of urology : official journal of the Japanese Urological Association.

Response of Prostate-Specific Antigen after Androgen Withdrawal and Prognosis in Men with Metastatic Prostate Cancer

Y. Furuya, K. Akakura, T. Igarashi, 1998, Urologia Internationalis.